http://onbiovc.com Your Source for BioScience Venture Capital Data Mon, 15 Mar 2010 00:58:25 +0000 http://backend.userland.com/rss092 en Valtech Cardio (Israel) a development-stage medical device company focused on minimally invasive percutaneous annuloplasty ring valve repair for the treatment of mitral valve regurgitation, closed a $17.8M Series B financing. Participants include OXO Capital, NGN Capital and Peregrine Ventures. http://onbiovc.com/valtech-cardio-ltd-series-b-178m/ OrthAlign (Irvine, CA) a commercial-stage medical device company focused on tibial alignment in total knee arthroplasty, closed a $5.2M Series A financing. Participants include California Technology Ventures, Okapi Venture Capital and Research Corporation Technologies. http://onbiovc.com/orthalign-inc-series-a-52m/ Somnus Therapeutics (Bedminster, NJ) a clinical-stage specialty pharmaceutical company focused on a delayed-release sleep-maintenance therapy, closed a $15M Series A financing. Participants include CTI Life Sciences Fund and Care Capital. http://onbiovc.com/somnus-therapeutics-inc-series-a-15m/ Site traffic and subscribers have both been on the rise here at OnBioVC.com; we are both humbled and appreciative for this growth, and that is why now, it is important to listen to what the OnBioVC market desires as our growth trajectory is architected. To date content at OnBioVC.com has been ... http://onbiovc.com/onbiovc-welcome%e2%80%a6new-feature-friday%e2%80%a6maybe/ The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation. Whilst many continue to pound the drum echoing the sentiment that limited partners remain sidelined, here is additional demonstration of continued new capital formation in the life science ... http://onbiovc.com/orbimed-looking-for-some-more-of-this/ OnBioVC would like to thank our sponsors, without whom complete coverage of the life science venture capital, M&A and IPO sector would not be possible: Freestone Group | Integrated Solutions for Emerging Life Science Companies MORE INFO AT: http://www.TheFreestoneGroup.com CONTACT: Jim Lewis jlewis@thefreestonegroup.com Regulus Pharmaceutical Consulting | Regulatory Affairs – Quality Assurance ... http://onbiovc.com/onbiovc-thanks-to-our-sponsors/ Nautilus Neurosciences (Bridgewater, NJ) near commercial-stage specialty neurology pharma focused on migraine and acute pain, closed a $14.5M Series A financing. Participants include Tailwind Capital. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well...this Friday! http://onbiovc.com/nautilus-neurosciences-inc-series-a-145m/ NABsys (Providence, RI) a development-stage company focused on polymerase-free solid-state electronic detection DNA sequencing free of amplification or labeling focused point-of-care clinical use, closed a $7M Series B financing. Participants include Stata Venture Partners and Point Judith Capital. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well...this Friday! http://onbiovc.com/nabsys-inc-series-b-7m/ Eleven Biotherapeutics (Cambridge, MA) a preclinical-stage biopharmaceutical company focused on protein therapeutics for the treatment of inflammation and coagulation disorders, closed a $35M Series A financing. Participants include Flagship Ventures and Third Rock Ventures. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well...this Friday! http://onbiovc.com/eleven-biotherapeutics-inc-series-a-35m/ Pulmonx (Redwood City, CA) a commercial-stage medical device company focused on minimally invasive devices for the diagnosis and treatment of COPD and other pulmonary disorders, closed a $32M Series C financing. Participants include HealthCap, Kleiner Perkins Caufield & Byers, De Novo Ventures, Latterell Venture Partners, MedVenture Associates, Montreux Equity Partners ... http://onbiovc.com/pulmonx-inc-series-c-32m/